The roles of surfactant proteins A and D in innate immunity

Immunological Reviews

Volumn 173, Issue , 2000, Pages 66-78

  Lawson, Peter R ^a   Reid, Kenneth B M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLECTIN; LECTIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ALLERGY; CHEMOTAXIS; CRYSTAL STRUCTURE; DNA POLYMORPHISM; GENETIC LINKAGE; HOST RESISTANCE; IMMUNITY; KNOCKOUT MOUSE; LUNG INFECTION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

BINDING SITES; GLYCOPROTEINS; HUMANS; LECTINS; LUNG; MODELS, MOLECULAR; PROTEIN BINDING; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS;

EID: 0033983738     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.917308.x     Document Type: Review

References (140)

1. 1. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994;8:957-967.
2. 2. Bezouska K, Crichlow GV, Rose JM, Taylor ME, Drickamer K. Evolutionary conservation of intron position in a subfamily of genes encoding carbohydrate-recognition domains. J Biol Chem 1991;266:11604-11609.
3. 3. Malhotra R, Haurum J, Thiel S, Sim RB. Interaction of C1q receptor with lung surfactant protein A. Eur J Immunol 1992;22:1437-1445.
4. 4. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996;17:532-540.
5. 5. Ikeda K, Sannoh T, Kawasaki N, Kawasaki T, Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987;262:7451-7454.
6. 6. Hoppe HJ, Barlow PN, Reid KB. A parallel three stranded α-helical bundle at the nucleation site of collagen triple-helix formation. FEBS Lett 1994;344:191-195.
7. 7. Lu J, Wiedemann H, Timpl R, Reid KB. Similarity in structure between C1q and the collectins as judged by electron microscopy. Behring Inst Mitt 1993;93:6-16.
8. 8. LaForce FM, Kelly WJ, Huber GL. Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material. Am Rev Respir Dis 1973;108:784-790.
9. 9. Tenner AJ, Robinson SL, Borchelt J, Wright JR. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR-and CR1-mediated phagocytosis. J Biol Chem 1989;264:13923-13928.
10. 10. Van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, van Golde LM. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990;2:91-98.
11. 11. Ohkuro M, Kobayashi K, Takahashi K, Nagasawa S. Effect of C1q on the processing of immune complexes by human neutrophils. Immunology 1994;83:507-511.
12. 12. Kuan SF, Rust K, Crouch E. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest 1992;90:97-106.
13. 13. Lim BL, Wang JY, Holmskov U, Hoppe HJ, Reid KB. Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of its binding to lipopolysaccharides of gram-negative bacteria. Biochem Biophys Res Commun 1994;202:1674-1680.
14. 14. Van Iwaarden JF, et al. Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J 1994;303:407-411.
15. 15. Pikaar JC, Voorhout WF, van Golde LM, Verhoef J, Van Strijp JA, van Iwaarden JF. Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages. J Infect Dis 1995;172:481-489.
16. 16. Kalina M, Blau H, Riklis S, Kravtsov V. Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. Am J Physiol 1995;268:L144-L151.
17. 17. Sano H, Sohma H, Muta T, Nomura S, Voelker DR, Kuroki Y. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol 1999;163:387-395.
18. 18. Stamme C, Wright JR. Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages. Am J Physiol 1999;276:L540-547.
19. 19. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJD. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992;89:143-149.
20. 20. Madan T, et al. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol 1997;110:241-249.
21. 21. Schelenz S, Malhotra R, Sim RB, Holmskov U, Bancroft GJ. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun 1995;63:3360-3366.
22. 22. Madan T, et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997;65:3171-3179.
23. 23. McNeely TB, Coonrod JD. Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am J Respir Cell Mol Biol 1994;11:114-122.
24. 24. Kabha K, Schmegner J, Keisari Y, Parolis H, Schlepper Schaeffer J, Ofek I. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 1997;272:L344-L352.
25. 25. O'Riordan DM, Standing JE, Kwon KY, Chang D, Crouch EC, Limper AH. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest 1995;95:2699-2710.
26. 26. Cai GZ, Griffin GL, Senior RM, Longmore WJ, Moxley MA. Recombinant SP-D carbohydrate recognition domain is a chemoattractant for human neutrophils. Am J Physiol 1999;276:L131-L136.
27. 27. Pison U, Wright JR, Hawgood S. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages. Am J Physiol 1992;262:L412-L417.
28. 28. Wright JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 1993;264:L338-L344.
29. 29. Crouch EC, Persson A, Griffin GL, Chang D, Senior RM. Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes. Am J Respir Cell Mol Biol 1995;12:410-415.
30. 30. Tino MJ, Wright JR. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages. Am J Physiol 1999;276:L164-L174.
31. 31. Manz Keinke H, Plattner H, Schlepper Schafer J. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur J Cell Biol 1992;57:95-100.
32. 32. Ohmer Schrock D, Schlatterer C, Plattner H, Schlepper Schafer J. Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages. J Cell Sci 1995;108:3695-3702.
33. 33. Tino MJ, Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 1996;270:L677-L688.
34. 34. Geertsma MF, Nibbering PH, Haagsman HP, Daha MR, van Furth R. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am J Physiol 1994;267:L578-L584.
35. 35. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995;155:5343-5351.
36. 36. Williams MD, Wright JR, March KL, Martin WJ. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Respir Cell Mol Biol 1996;14:232-238.
37. 37. Hartshorn KL, et al. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998;274:L958-L969.
38. 38. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998;19:700-708.
39. 39. Tenner AJ. Membrane receptors for soluble defense collagens. Curr Opin Immunol 1999;11:34-41.
40. 40. Kuan SF, Persson A, Parghi D, Crouch E. Lectin-mediated interactions of surfactant protein D with alveolar macrophages. Am J Respir Cell Mol Biol 1994;10:430-436.
41. 41. Miyamura K, Leigh LE, Lu J, Hopkin J, Lopez Bernal A, Reid KB. Surfactant protein D binding to alveolar macrophages. Biochem J 1994;300:237-242.
42. 42. Manz Keinke H, Egenhofer C, Plattner H, Schlepper Schafer J. Specific interaction of lung surfactant protein A (SP-A) with rat alveolar macrophages. Exp Cell Res 1991;192:597-603.
43. 43. Wintergerst E, Manz Keinke H, Plattner H, Schlepper Schafer J. The interaction of a lung surfactant protein (SP-A) with macrophages is mannose dependent. Eur J Cell Biol 1989;50:291-298.
44. 44. Van Iwaarden JF, van Strijp JA, Visser H, Haagsman HP, Verhoef J, van Golde LM. Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. J Biol Chem 1992;267:25039-25043.
45. 45. Van Iwaarden JF, Shimizu H, Van Golde PH, Voelker DR, Van Golde LM. Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages. Biochem J 1992;286:5-8.
46. 46. Weissbach S, Neuendank A, Pettersson M, Schaberg T, Pison U. Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages. Am J Physiol 1994;267:L660-L666.
47. 47. Van Iwaarden JF, Teding van Berkhout F, Whitsett JA, Oosting RS, van Golde LM. A novel procedure for the rapid isolation of surfactant protein A with retention of its alveolar-macrophage-stimulating properties. Biochem J 1995;309:551-555.
48. 48. Hartshorn KL, et al. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest 1994;94:311-319.
49. 49. Hickman Davis JM, Lindsey JR, Zhu S, Matalon S. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am J Physiol 1998;274:L270-L277.
50. 50. Blau H, Riklis S, Van Iwaarden JF, McCormack FX, Kalina M. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. Am J Physiol 1997;272:L1198-L1204.
51. 51. Hickman Davis J, Gibbs Erwin J, Lindsey JR, Matalon S. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc Natl Acad Sci USA 1999;96:4953-4958.
52. 52. Acton S, Resnick D, Freeman M, Ekkel Y, Ashkenas J, Krieger M. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J Biol Chem 1993;268:3530-3537.
53. 53. Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol 1998;161:4599-4603.
54. 54. Borron P, et al. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am J Physiol 1998;275:L679-L686.
55. 55. Wang JY, Shieh CC, You PF, Lei HY, Reid KB. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 1998;158:510-518.
56. 56. Chen A, Gaddipati S, Hong Y, Volkman DJ, Peerschke EI, Ghebrehiwet B. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol 1994;153:1430-1440.
57. 57. McIntosh JC, Mervin Blake S, Conner E, Wright JR. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages. Am J Physiol 1996;271:L310-L319.
58. 58. Hickling TP, Sim RB, Malhotra R. Induction of TNF-α release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A. FEBS Lett 1998;437:65-69.
59. 59. Malhotra R, Haurum J, Thiel S, Jensenius JC, Sim RB. Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A). Biosci Rep 1993;13:79-90.
60. 60. Wang JY, Kishore U, Lim BL, Strong P, Reid KB. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin Exp Immunol 1996;106:367-373.
61. 61. Cheng G, et al. Suppressive effects of SP-A on ionomycin-induced IL-8 production and release by eosinophus. Int Arch Allergy Immunol 1998;117(Suppl 1):59-62.
62. 62. Borron P, et al. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am J Respir Cell Mol Biol 1996;15:115-121.
63. 63. Jobe AH, Ikegami M. Surfactant and acute lung injury. Proc Assoc Am Physicians 1998;110:489-495.
64. 64. Postle AD, et al. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol 1999;20:90-98.
65. 65. Kerr MH, Paton JY. Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med 1999;159:1115-1118.
66. 66. Gunther A, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996;153:176-184.
67. 67. Baker CS, Evans TW, Randle BJ, Haslam PL. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999;353:1232-1237.
68. 68. Hickling TP, Malhotra R, Sim RB. Human lung surfactant protein A exists in several different oligomeric states: oligomer size distribution varies between patient groups. Mol Med 1998;4:266-275.
69. 69. Arbibe L, et al. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 1998;102:1152-1160.
70. 70. Reading PC, Allison J, Crouch EC, Anders EM. Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J Virol 1998;72:6884-6887.
71. 71. Miakotina OL, Dekowski SA, Snyder JM. Insulin inhibits surfactant protein A and B gene expression in the H441 cell line. Biochim Biophys Acta 1998;1442:60-70.
72. 72. Snyder JM, Kwun JE, O'Brien JA, Rosenfeld CR, Odom MJ. The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr Res 1988;24:728-734.
73. 73. Karinch AM, Deiter G, Ballard PL, Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture. Biochim Biophys Acta 1998;1398:192-202.
74. 74. Hoover RR, Floros J. SP-A 3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol 1999;276:L917-L924.
75. 75. Scavo LM, Ertsey R, Gao BQ. Human surfactant proteins A1 and A2 are differentially regulated during development and by soluble factors. Am J Physiol 1998;275:L653-L669.
76. 76. Goss KL, Kumar AR, Snyder JM. SP-A2 gene expression in human fetal lung airways. Am J Respir Cell Mol Biol 1998;19:613-621.
77. 77. Saitoh H, Okayama H, Shimura S, Fushimi T, Masuda T, Shirato K. Surfactant protein A2 gene expression by human airway submucosal gland cells. Am J Respir Cell Mol Biol 1998;19:202-209.
78. 78. Floros J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998;1408:312-322.
79. 79. Karinch AM, Floros J. 5′ splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol 1995;12:77-88.
80. 80. Karinch AM. deMello DE, Floros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J 1997;321:39-47.
81. 81. Kala P, Ten Have T, Nielsen H, Dunn M, Floros J. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 1998;43:169-177.
82. 82. Hoover RR, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 1998;18:353-362.
83. 83. Bruns G, Stroh H. Veldman GM, Latt SA, Floros J. The 35 kd pulmonary surfactant-associated protein is encoded on chromosome 10. Hum Genet 1987;76:58-62.
84. 84. Fisher JH, Kao FT, Jones C, White RT, Benson BJ, Mason RJ. The coding sequence for the 32,000-dalton pulmonary surfactant-associated protein A is located on chromosome 10 and identifies two separate restriction-fragment-length polymorphisms. Am J Hum Genet 1987;40:503-511.
85. 85. Korfhagen TR, Classer SW, Bruno MD, McMahan MJ, Whitsett JA. A portion of the human surfactant protein A (SP-A) gene locus consists of a pseudogene. Am J Respir Cell Mol Biol 1991;4:463-469.
86. 86. Crouch E, Rust K, Veile R, Donis Keller H, Grosso L. Genomic organization of human surfactant protein D (SP-D). SP-D is encoded on chromosome 10q22.2-23.1. J Biol Chem 1993;268:2976-2983.
87. 87. Sastry K, et al. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 1989;170:1175-1189.
88. 88. Lawson PR, Perkins VC, Holmskov U, Reid KBM. Genomic organisation of the mouse gene for lung surfactant protein D (Sftpd). Am J Respir Cell Mol Biol 1999;20:953-963.
89. 89. Korfhagen TR, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996;93:9594-9599.
90. 90. Ikegami M, et al. Surfactant metabolism in surfactant protein A-deficient mice. Am J Physiol 1997;272:L479-L485.
91. 91. Ikegami M, et al. Characteristics of surfactant from SP-A-deficient mice. Am J Physiol 1998;275:L247-L254.
92. 92. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997;158:4336-4340.
93. 93. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999;103:1015-1021.
94. 94. LeVine AM, et al. Surfactant protein-A binds group B Streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 1999;20:279-286.
95. 95. Korfhagen TR, et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998;273:28438-28443.
96. 96. Botas C, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998;95:11869-11874.
97. 97. Lin S, Na CL, Akinbi HT, Apsley KS, Whitsett JA, Weaver TE. Surfactant protein B (SP-B) -/-mice are rescued by restoration of SP-B expression in alveolar type II cells but not clara cells. J Biol Chem 1999;274:19168-19174.
98. 98. McCormack FX, Calvert HM, Watson PA, Smith DL, Mason RJ, Voelker DR. The structure and function of surfactant protein A. Hydroxyproline-and carbohydrate-deficient mutant proteins. J Biol Chem 1994;269:5833-5841.
99. 99. McCormack FX, Stewart J, Voelker DR, Damodarasamy M. Alanine mutagenesis of surfactant protein A reveals that lipid binding and pH-dependent liposome aggregation are mediated by the carbohydrate recognition domain. Biochemistry 1997;36:13963-13971.
100. 100. Kuroki Y, McCormack FX, Ogasawara Y, Mason RJ, Voelker DR. Epitope mapping for monoclonal antibodies identifies functional domains of pulmonary surfactant protein A that interact with lipids. J Biol Chem 1994;269:29793-29800.
101. 101. Pattanajitvilai S, Kuroki Y, Tsunezawa W, McCormack FX, Voelker DR. Mutational analysis of Arg 197 of rat surfactant protein A. His 197 creates specific lipid uptake defects. J Biol Chem 1998;273:5702-5707.
102. 102. McCormack FX, Pattanajitvilai S, Stewart J, Possmayer F, Inchley K, Voelker DR. The Cys6 intermolecular disulfide bond and the collagen-like region of rat SP-A play critical roles in interactions with alveolar type II cells and surfactant lipids. J Biol Chem 1997;272:27971-27979.
103. 103. Zhang M, Damodarasamy M, Elhalwagi BM, McCormack FX. The longer isoform and Cys-1 disulfide bridge of rat surfactant protein A are not essential for phospholipid and type II cell interactions. Biochemistry 1998;37:16481-16488.
104. 104. Eda S, et al. Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus. Biochem J 1997;323:393-399.
105. 105. Brown Augsburger P, et al. Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties. J Biol Chem 1996;271:13724-13730.
106. 106. Brown Augsburger P, Chang D, Rust K, Crouch EC. Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion. J Biol Chem 1996;271:18912-18919.
107. 107. Hartshorn K, Chang D, Rust K, White M, Heuser J, Crouch E. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am J Physiol 1996;271:L753-L762.
108. 108. Hartshorn KL, et al. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood 1996;87:3450-3461.
109. 109. Crouch E, Persson A, Chang D. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol 1993;142:241-248.
110. 110. Persson A, Chang D, Crouch E. Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. J Biol Chem 1990;265:5755-5760.
111. 111. Hakansson K, Lim NK, Hoppe HJ, Reid KB. Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure 1999;7:255-264.
112. 112. Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992;360:127-134.
113. 113. Voorhout WF, Veenendaal T, Kuroki Y, Ogasawara Y, van Golde LM, Geuze HJ. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem 1992;40:1589-1597.
114. 114. Crouch E, Parghi D, Kuan SF, Persson A. Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am J Physiol 1992;263:L60-66.
115. 115. Crouch E, Persson A, Chang D, Parghi D. Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis. Am J Pathol 1991;139:765-776.
116. 116. Wong CJ, Akiyama J, Allen L, Hawgood S. Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse. Pediatr Res 1996;39:930-937.
117. 117. Fisher JH, Mason R. Expression of pulmonary surfactant protein D in rat gastric mucosa. Am J Respir Cell Mol Biol 1995;12:13-18.
118. 118. Motwani M, White RA, Guo N, Dowler LL, Tauber AI, Sastry KN. Mouse surfactant protein-D. cDNA cloning, characterization, and gene localization to chromosome 14. J Immunol 1995;155:5671-5677.
119. 119. Lu J. Collectins: collectors of microorganisms for the innate immune system. Bioessays 1997;19:509-518.
120. 120. Rubio S, et al. Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine. J Biol Chem 1995;270:12162-12169.
121. 121. Eliakim R, et al. Isolation and characterization of surfactant-like particles in rat and human colon. Am J Physiol 1997;272:G425-G434.
122. 122. Chailley-Heu B, et al. Expression of hydrophilic surfactant proteins by mesentery cells in rat and man. Biochem J 1997;328:251-256.
123. 123. Kasper M, Albrecht S, Grossmann H, Grosser M, Schuh D, Muller M. Monoclonal antibodies to surfactant protein D: evaluation of immunoreactivity in normal rat lung and in a radiation-induced fibrosis model. Exp Lung Res 1995;21:577-588.
124. 124. Ogasawara Y, Kuroki Y, Shiratori M, Shimizu H, Miyamura K, Akino T. Ontogeny of surfactant apoprotein D, SP-D, in the rat lung. Biochim Biophys Acta 1991;1083:252-256.
125. 125. Crouch E, Rust K, Marienchek W, Parghi D, Chang D, Persson A. Developmental expression of pulmonary surfactant protein D (SP-D). Am J Respir Cell Mol Biol 1991;5:13-18.
126. 126. Mendelson CR, Boggaram V Hormonal control of the surfactant system in fetal lung. Annu Rev Physiol 1991;53:415-440.
127. 127. McNeely TB, Coonrod JD. Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis 1993;167:91-97.
128. 128. Limper AH, et al. Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J Lab Clin Med 1995;126:416-422.
129. 129. McCormack FX, Festa AL, Andrews RP, Linke M, Walzer PD. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii. Biochemistry 1997;36:8092-8099.
130. 130. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998;19:177-201.
131. 131. Rosseau S, Guenther A, Seeger W, Lohmeyer J. Phagocytosis of viable Candida albicans by alveolar macrophages: lack of opsonin function of surfactant protein A. J Infect Dis 1997;175:421-428.
132. 132. Walenkamp AM, Verheul AF, Scharringa J, Hoepelman IM. Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur J Clin Invest 1999;29:83-92.
133. 133. Malhotra R, Haurum JS, Thiel S, Sim RB. Binding of human collectins (SP-A and MBP) to influenza virus. Biochem J 1994;304:455-461.
134. 134. Benne CA, et al. Interactions of surfactant protein A with influenza A viruses: binding and neutralization. J Infect Dis 1995;171:335-341.
135. 135. Benne CA, Benaissa Trouw B, van Strijp JA, Kraaijeveld CA, van Iwaarden JF. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur J Immunol 1997;27:886-890.
136. 136. Van Iwaarden JF, van Strijp JA, Ebskamp MJ, Welmers AC, Verhoef J, van Golde LM. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am J Physiol 1991;261:L204-L209.
137. 137. Weikert LF, Edwards K, Chroneos ZC, Hager C, Hoffman L, Shepherd VL. SP-A enhances uptake of bacillus Calmette-Guérin by macrophages through a specific SP-A receptor. Am J Physiol 1997;272:L989-L995.
138. 138. Hickman Davis JM, Michalek SM, Gibbs Erwin J, Lindsey JR. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect Immun 1997;65:2278-2282.
139. 139. Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 1999;163:312-321.
140. 140. Downing JF, Pasula R, Wright JR, Twigg HLD, Martin WJ. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci USA 1995;92:4848-4852.